List of 2020 Speakers

2020 Conference Speakers

Keynote Speaker:
Michael Varney,
PhD, Executive Vice President, Genentech Research & Early Development

Conference Speakers:
Jeremy Bender, PhD, MBA, Vice President Corporate Development, Gilead Sciences
Issac Cheng, MD, Investment Professional, Morningside
Sean Harper, MD, Founding Managing Director, Westlake Village Biopartners
Chris Haskell, PhD, Vice President and Head of West Coast Innovation Center, Bayer
John Hood,
PhD, Founder & Board Chairman, Endeavor Biosciences
Catriona Jamieson, MD, PhD, Professor of Medicine in the Division of Hematology-Oncology, Deputy Director at UC San Diego Moores Cancer Center, Koman Family Presidential Endowed Chair in Cancer Research, Chief of the Division of Regenerative Medicine, Deputy Director of the Sanford Stem Cell Clinical Center, Co-Leader of the Hematologic Malignancies Program, and Director of Stem Cell Research at UC San Diego Moores Cancer Center
Rachna Khosla, MBA, Vice President, Business Development, Amgen
Ken Kubota, VP, Astellas Pharma
Angele Maki, PhD, Vice President, Emerging Technology & Innovation, Eli Lilly & Company
Carole NuechterleinHead, Roche Venture Fund
Scott Platshon, Principal, EcoR1
Ioannis Sapountzis
, PhD, Corporate Senior Vice President, Business Development, Boehringer Ingelheim Pharmaceuticals, Inc.
Uwe Schoenbeck, PhD, Senior Vice President and Chief Scientific Officer, Emerging Science and Innovation (ES&I), Pfizer Worldwide Research, Development, and Medical
Bavani Shankar, MBA, Head of Transactions, Business Development & Licensing, AstraZeneca BioPharmaceuticals R&D
Avi Spier, Head, Search & Evaluation, Novartis
Alex Szidon, PhD, Vice President and Head of Business Development, gRED at Genentech
Marianne De Backer,
PhD, MBA, EVP, Global Head Business Development & Licensing, Member of the Executive Committee, Bayer
Ben Thorner, SVP and Head of BD&L, Merck
Jeffrey Warmke, PhD, Senior Vice President, Search and Evaluation & Alliance Management, Global Business Development, Daiichi Sankyo
Timothy Wright, MD, General Partner,TIME BioVentures